CVA
PTEN icon

Ceredex Value Advisors’s Patterson-UTI PTEN Stock Holding History

Ceredex Value Advisors’s Portfolio PTEN Stock Details PTEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,363,150
Closed -$11.2M – 189
2025
Q1 		$11.2M Buy
1,363,150
+32,800
+2% +$275K 0.25% 133
2024
Q4 		$11M Buy
1,330,350
+84,950
+7% +$681K 0.22% 132
2024
Q3 		$9.53M Buy
1,245,400
+84,200
+7% +$776K 0.19% 140
2024
Q2 		$12M Buy
+1,161,200
New +$12.7M 0.23% 115
2023
Q2 		– Sell
-972,800
Closed -$11.4M – 180
2023
Q1 		$11.4M Buy
+972,800
New +$14.2M 0.18% 134
2018
Q4 		– Sell
-2,432,500
Closed -$41.6M – 180
2018
Q3 		$41.6M Buy
2,432,500
+362,550
+18% +$6.23M 0.47% 84
2018
Q2 		$37.3M Buy
2,069,950
+33,300
+2% +$668K 0.43% 103
2018
Q1 		$35.7M Buy
+2,036,650
New +$42.5M 0.42% 111

Other funds holding PTEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $2.48B AUM 72.25% 1-Year Est. Return
AIM
ARGA Investment Management Stamford, Connecticut $3.05B AUM 47.96% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Ceredex Value Advisors's PTEN Position: Q2 2025 in Review

Ceredex Value Advisors sold out of Patterson-UTI (PTEN) in Q2 2025, closing a stake of 1,363,150 shares — an estimated $11.2M sold.

Ceredex Value Advisors first reported a position in PTEN in Q1 2018 and held it in 8 quarters. The position peaked at $41.6M in Q3 2018. 361 funds tracked by Wall St. Rank hold PTEN as of Q2 2025.

  • Ceredex Value Advisors reported no remaining Patterson-UTI position as of Q2 2025 after selling out during the quarter.
  • Ceredex Value Advisors sold 1,363,150 Patterson-UTI shares in Q2 2025, an estimated $11.2M.
  • Ceredex Value Advisors first reported a position in Patterson-UTI in Q1 2018 and held it in 8 quarters.
  • Ceredex Value Advisors's Patterson-UTI position peaked at $41.6M in Q3 2018.
  • 361 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2025.

Based on Ceredex Value Advisors's 13F filing for Q2 2025, filed 13 Aug 2025.